Impact of seasonal malaria chemoprevention on prevalence of malaria infection in malaria indicator surveys in Burkina Faso and Nigeria

BACKGROUND: In 2012, the WHO issued a policy recommendation for the use of seasonal malaria chemoprevention (SMC) to children 3–59 months in areas of highly seasonal malaria transmission. Clinical trials have found SMC to prevent around 75% of clinical malaria. Impact under routine programmatic cond...

Descripción completa

Detalles Bibliográficos
Autores principales: de Cola, Monica Anna, Sawadogo, Benoît, Richardson, Sol, Ibinaiye, Taiwo, Traoré, Adama, Compaoré, Cheick Saïd, Oguoma, Chibuzo, Oresanya, Olusola, Tougri, Gauthier, Rassi, Christian, Roca-Feltrer, Arantxa, Walker, Patrick, Okell, Lucy C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121431/
https://www.ncbi.nlm.nih.gov/pubmed/35589153
http://dx.doi.org/10.1136/bmjgh-2021-008021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121431/
https://www.ncbi.nlm.nih.gov/pubmed/35589153
http://dx.doi.org/10.1136/bmjgh-2021-008021

Ejemplares similares